Medicare weight-loss drug copays vary, but the average out-of-pocket cost to obtain GLP-1s through Part D at the end of 2025 was $167 per month and climbing, according to a study by researchers at University of Pennsylvania
BCA, Bis-creatine
A plan sponsor paying $50 per unit for a generic drug while the PBM reimburses the pharmacy $30 generates $20 per unit in spread revenue for the PBM
Layer rapid weight loss on top with its own oestrogen-reducing effect and you have two simultaneous mechanisms working against your hair
This is one way tirzepatide works for weight loss
GLP-1 agonists affect diverse obesity etiopathogenic processes such as abnormal food intake regulation, adipocyte dysfunction, insulin resistance, adipokine production, inflammation, endothelial dysfunction, lipid metabolism, and oxidative stress